Rodríguez Villodres A, Gálvez Benítez L, Arroyo MJ, Méndez G, Mancera L, Vila Domínguez A, Lepe Jímenez JA, Smani Y*. Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpipta test. Emerging Microbes and Infections 2022; 11(1): 2034-2044. (* autor de correspondencia).
Gil-Marqués ML, Pachón J, Smani Y*. iTRAQ-based quantitative proteomic analysis of Acinetobacter baumannii under hypoxia and normoxia reveals the role of OmpW as a virulence factor. Microbiology Spectrum; in press.
Gil-Marqués ML, Labrador Herrera G, Miró Canturri A, Pachón J, Smani Y*, Pachón-Ibáñez ME. Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia. Journal of Infectious Diseases 2020; 222(7): 1204-1212.
Vila-Farrés X, Parra-Millán R, Sánchez-Encinales V, Varese M, Ayerbe-Algaba R, Bayó N, Guardiola S, Pachón-Ibáñez ME, Kotev M, García J, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y. Combating virulence of Gram-negative bacilli by OmpA inhibition. Scientific Reports 2017; 7(1): 14683.
Pachón-Ibáñez ME#, Smani Y#, Pachón J, Sánchez-Céspedes J. Perspectives for clinical use of engineered human host defense antimicrobial peptides. FEMS Microbiology Reviews 2017; 41(3): 323-342. (co-first author)
Smani Y*, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Ibáñez-Martínez J, Pachón J. Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells. Journal of Biological Chemistry 2012; 287(32): 26901-10.
